| 000 | 01489 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518032517.0 | ||
| 264 | 0 | _c20200330 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1750-7448 | ||
| 024 | 7 |
_a10.2217/imt-2019-0022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoescher, Johannes | |
| 245 | 0 | 0 |
_aImmunotherapy for head and neck cancers: an update and future perspectives. _h[electronic resource] |
| 260 |
_bImmunotherapy _c05 2019 |
||
| 300 |
_a561-564 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xtrends |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aNK Cell Lectin-Like Receptor Subfamily C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 700 | 1 | _aLaban, Simon | |
| 700 | 1 | _aSchuler, Patrick J | |
| 700 | 1 | _aBrunner, Cornelia | |
| 700 | 1 | _aHoffmann, Thomas K | |
| 773 | 0 |
_tImmunotherapy _gvol. 11 _gno. 7 _gp. 561-564 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt-2019-0022 _zAvailable from publisher's website |
| 999 |
_c29548434 _d29548434 |
||